Objective: This study investigates the potential estrogenic activity of the ethanolic extract of Flemingia vestita Benth tubers using ovariectomized rat model. Materials and Methods: The ethanolic extract of F. vestita tubers has been standardized using validated HPLC method in terms of its genistein content (8.43 ± 0.05 mg/g of extract). Three to four week old young albino Wistar female rats were ovariectomized and treated for 14 days post ovariectomy with the standardized ethanolic extract at three different dose levels (100, 250, 500 mg/kg body weight) with a positive control of Estradiol valerate (1 mg/kg/day). The parameters evaluated were uterine weight, uterine glycogen, G6PDH, LDH, 17β-estradiol, progesterone, total cholesterol, triglycerides, HDL and histo architecture of uterus. Results: Treatment with the ethanolic extract of F. vestita tubers showed dose dependent increase in uterine weight, glycogen levels, G6PDH levels, estrogen and progesterone levels when compared with the ovariectomized control. Amongst three dose levels, high dose of plant extract showed significant increase in the uterine weight (p < 0.001), uterine glycogen content (p < 0.001), 17-β estradiol and progesterone levels (p < 0.001), G6PDH and LDH levels (p < 0.001) as well as significant decrease in HDL and triglycerides levels (p < 0.001) compared to ovariectomized control. Histopathological evaluation of uteri sections revealed that the high dose of the plant show increase in the endometrial response as indicated by proliferation of endometrial glands and luminal epithelium of the ovariectomized rats. Conclusion: Thus, these data suggests that ethanolic extract (500 mg/kg body weight) of F. vestita tubers may exhibit good estrogenic activity in ovariectomized rat model.
INTRODUCTION
Phytoestrogens, specifically isoflavones, are receiving great commercial interest at present. As these phytoesterogens have structural similarity to estrogenic steroids in human body, they mimic the effects of naturally occurring estrogenic compounds. Specifically the biological effects associated with ingesting isoflavones indicate that dietary supplements rich in these compounds might be useful for alleviating menopausal health concerns.
1-2 Several medicinal plants have been evaluated for their estrogenic activity either individually or in the form of polyherbal combination. [3] [4] [5] [6] [7] [8] There have been very few studies on the pharmacological validation of the plants that are used for the treatment of diseases in North-East India. One such plant is Flemingia vestita Benth (Soh-phlang, Fabaceae); an indigenous plant of Meghalaya, found practically throughout the Himalayas and Khasi Hills up to an elevation of 8,000 ft. 9 The plant is known for its fleshy tubers which are scientifically evaluated against intestinal helminthes infections. [10] [11] These tubers are consumed by local people of Meghalaya to cure intestinal infections. 12 These tubers possess major isoflavones like formononetin, diadzein, genistein, etc. [13] [14] [15] Genistein is known to have a wide spectrum of biological activities, 16 estrogenic activity being one of its most remarkable properties. [17] [18] Moreover, no research so far has been conducted to assess estrogenic potential of F. vestita. Hence, the present study aimed to evaluate the estrogenic activity of standardized extract of F. vestita tubers in ovariectomized rat model.
MATERIALS AND METHODS

Plant materials
Fresh tubers of F. vestita were collected from Shillong (Meghalaya) and authenticated from Department of Botany, North East Hill University, Shillong. The tubers were thoroughly washed, cleaned and shade dried for a week. The materials were then packed in absorbent paper; oven dried at 37°C for three days, powdered using a mixer-grinder and sieved (BSS mesh number 85).
Chemicals and reagents
Analytical grade solvents were purchased from Merck Specialities, Mumbai, India. Progynova® (Estradiol valerate tablets) was procured from Zydus Healthcare. Ketamine Hydrochloride ® injection was procured from Neon Laboratories Ltd. The estrogen and progesterone kits were obtained from Diametra, Italy and G6PDH kit was obtained from Avecon healthcare. The LDH reagent kit was obtained from Aspen Laboratories and cholesterol, HDL and triglycerides kits were obtained from Span diagnostics. Standard genistein (98% purity) was procured from Sigma Aldrich Chemical Company (Steinheim, Germany). Healex plus spray was procured from Shreya Life Sciences Pvt. Ltd. Surgical staplers were obtained from Eticon Endo Surgery (Mexico).
Preparation of ethanolic extract and standardization
Fine powder of F. vestita tubers (300 g) was extracted with ethanol (1500 mL, 5X) by refluxing on heating mantle (30 %) for 5 h. The mixture was filtered through Whatmann filter No. 1 and the filtrate was evaporated under reduced pressure using a rota evaporator at 45°C. The extract was standardized in terms of genistein content using validated HPLC method. 19 Separation was achieved on Cosmosil C 18 -column (150 mm x 4.6 mm, 5.0 μm) using mobile phase 0.025 M phosphate buffer (in water): acetonitrile (68: 32, v/v, pH 2.4) delivered at a flow rate of 1 mL/min. The peaks were recorded at 261 nm using PDA detector (MD-1510). The presence of genistein in the extract was also confirmed using LC-MS technique. Mass spectrometric analysis was performed on an API Applied Biosystems Hybrid Q-Trap API 2000 Mass Spectrometer (AB-MDS Sciex, Toronto, Canada) equipped with an electrospray ionization source (ESI).
Animals
Albino Wistar female rats weighing 150-180 g and 180-220 g were used for safety and estrogenic study, respectively. Animals were obtained from Haffkine Biopharmaceuticals, Parel and were housed in polypropylene cages under regulated temperature of 22 ± 3°C, relative humidity of 60 ± 5 % and 12 h light-dark cycle. Animals were provided free access to standard water and food supplied by Amrut Feed. The experimental procedures and protocol for the safety (AMM-130626-01) and efficacy (AMM-130626-02) study were reviewed and approved by the Institutional Animal Ethics Committee (IAEC) of Ramnarain Ruia College, Mumbai (CPCSEA/315).
Safety evaluation
The safety of the standardized ethanolic extract of F. vestita was evaluated in female albino Wistar rats at a dose of 2000 mg/kg as per OECD guidelines No. 420. 20 The animals were randomly grouped into three groups of five animals each. Group I served as normal control received Distilled water, Group II served as vehicle control received 1 % CMC and Group III received ethanolic extract of F. vestita tubers. After dosing, the animals were observed after every 30 min till 2 h for immediate toxicity, periodically during the first 48 h and then daily for 14 days. Toxicity was evaluated on the basis of mortality, daily food and water intake, change in body weight and general behavioral changes.
Experimental design for evaluating estrogenic potential
Estrogenic potential of standardized extract of F. vestita was evaluated in ovariectomized rats at three different doses (100 mg/kg, 250 mg/ kg and 500 mg/kg, body weight respectively). Histopathological parameters, uterine weight, glycogen content and biochemical parameters like 17-β estradiol, progesterone, lactate dehydrogenase (LDH), glucose-6-phosphatase (G6PDH), total cholesterol, triglycerides and High-density lipoprotein (HDL) were used to evaluate the estrogenic potential. Vaginal smear cytology was performed for the determination of rat estrous cycle phases and to ensure the regular cycles. Vaginal secretions were examined from all the animals every morning for 15 days. [21] [22] Rats showing diestrous phase (leukocyte cells) were selected for the procedure of ovariectomy. Albino Wistar female rats were randomized into six groups of six animals each. Animals from all the groups were ovariectomized (OVX) except the rats from the Group I that served as sham-operated control. In the sham-operated control, the ovaries were exposed and gently manipulated but not excised. On rest of the animals bilateral ovariectomy was performed via a dorso-lateral approach with a small lateral vertical skin incision followed by ligation and excision of the ovaries along the upper horn under general anesthesia with ketamine hydrochloride (100 mg/kg body weight, i.p.). [23] [24] The incisions were joined together with the help of surgical stapler followed by applying healex spray for quick healing of the wound. Care was taken to avoid any infection throughout the ovariectomy procedure. Animals were kept for the healing period of 14 days pre dosing. During the healing period, the animals were observed for any abnormal behavior or side effects. The animals were then randomized in 5 groups (except sham-operated control) on the basis of 17-β estradiol and progesterone levels. Animals showing reduced levels of estrogen and progesterone were then orally administered with their respective test samples as per dosage regimen for 14 consecutive days. The experimental groups were as follows; 
Blood collection procedure
Blood sample was withdrawn from all the animals prior to dosing (Day 0) and on day 15 (post dosing) by retro orbital plexus technique using heparinised capillaries. The whole blood, serum and plasma samples collected during the study were stored at -20°C until the determination of biochemical parameters.
Histopathological evaluation
The animals were sacrificed by cervical dislocation after blood collection. The left and right uterus of all the animals were removed after sacrifice, rinsed in saline, blotted and weighed. The weight of the uterus was expressed as mg/100 g body weight. 2 A portion of uterus was taken for the estimation of glycogen by anthrone method 26 and remaining was fixed in 10 % neutral buffered formalin and processed by paraffin technique. Sections of 5 μm thickness were cut and stained by routine hematoxylineosin (H&E) method for histopathological evaluation. 27 
Evaluation of Biochemical parameters
Serum samples were used to determine the 17-β estradiol and progesterone levels along with the estimation of LDH levels. The whole blood sample was used to estimate G6PDH levels whereas plasma samples were used to determine total cholesterol, HDL and triglycerides levels. The standard kits were used to evaluate biochemical parameters like 17-β estradiol, progesterone, G6PDH, LDH, total cholesterol, HDL and triglycerides levels.
Statistical analysis
Values are expressed as Mean ± SEM, n = 6. Graph Pad Prism5 software (version 5.03) was used for the statistical analysis of data. Data was analyzed using ANOVA followed by Dunnett's test. Values of p < 0.05 were considered significant.
RESULTS AND DISCUSSION
Tubers of Flemingia vestita Benth has been reported to possess phytoestrogens such as formononetin, pseudobaptigenin, diadzein and genistein. 15 Recently, much interest has been paid to phytoestrogens for their potential health benefits in counteracting menopausal symptoms and in lowering the incidence of hormone dependent diseases. 28 Genistein is one such phytoestrogen with a wide variety of pharmacological effects in animal cells, including tyrosine kinase inhibition, and dietary genistein ingestion has been linked, through epidemiological and animal model studies, with a range of potential health beneficial effects. These include chemoprevention of breast and prostate cancers, cardiovascular disease and post-menopausal ailments. 29 Hence, genistein was selected as a bioactive marker for evaluating the estrogenic potential of F. vestita tubers using ovariectomized rat model.
Standardized ethanolic extract of F. vestita
The ethanolic extract of the plant was standardized in terms of its genistein content (8.43 ± 0.05 mg/g) using a validated HPLC method reported previously. 19 The HPLC chromatograms of genistein and ethanolic extract of F. vestita are shown in Figure 1 .The presence of genistein in the ethanolic extract of F. vestita tubers was also confirmed by using LC-MS technique.
The molecular mass of genistein is 270.241. As the mass spectrometric analysis was carried out at negative ionization mode, the mass of genistein obtained was found to be 269.8 m/z. The peak corresponding to genistein was observed at m/z 269.8 in the Full scan Q1 MS spectrum of the ethanolic extract of F. vestita tubers confirming its presence (Figure 2 ).
Safety evaluation
The data of the acute oral toxicity studies on medicinal plants is necessary in order to increase the confidence in its safety to human, particularly for use in the development of pharmaceuticals. 30 Oral administration of the ethanolic extract of F. vestita tubers at a dose of 2000 mg/kg body weight did not show any toxic effect or mortality. Also, no significant change in the body weight, food intake and water intake of the animals was observed compared to the animals of control group. Hence, the extract had a wide margin of safety for oral use in rats (Data not shown).
Evaluation of estrogenic potential
Cage side observations during the efficacy study were found to be normal with no sign of abdominal dullness, subcutaneous slug, opacity and discharge for eyes and breathing abnormality.
Vaginal Cellular Differentiation
The estrous cycle is characterized by cyclical changes in uterus, ovaries, vaginal mucosa as well as behavioral and hormonal changes. 31 Vaginal cytology assay is particularly used to determine the estrogenic activity of the synthetic estrogens and phytoestrogens 21 as they induce the cornification of epithelial cells. After ovariectomy, all the rats had leukocytes population affirming complete removal of ovaries. 32 Vaginal smears of OVX rats did not show any cornification proving the absence of endogenous estrogens. Vaginal cells showed maturation in response to Estradiol valerate in 5 days during the 15 day exposure period. Similar observations were reported by Cordial et al., 2006 using 17β-Estradiol at a dose of 50µg/kg bd. wt. 2 FVH induced significant cornification of cells when compared to OVX control on 9 th day whereas FVM and FVL induced cornification of epithelium cells after 10 th and 13 th day of the exposure period. There are many preclinical and clinical studies reported on the effects of phytoestrogens on vaginal cytology maturation. [33] [34] In our study, the cornification of vaginal smear in OVX rats treated with F. vestita tubers was found to be dose dependent which can be attributed to its estrogenic potential.
Effect of ethanolic extract of F. vestita tubers on 17β-estradiol and Progesterone level
Ovarian hormones, estrogen and progesterone govern the primary changes in the uterine tissue. 8 All the animals after ovariectomy procedure showed significant decrease (p < 0.001) in the 17β-estradiol and progesterone levels compared to the animals of normal control group before dosing indicating complete removal of ovaries. After treatment for 14 days, animals treated with estradiol valerate showed a significant increase (p < 0.001) in the 17β-estradiol and progesterone levels compared to the animals of OVX control group. Similarly, animals treated with all the three doses of plant extract showed significant increase (p < 0.001) in 17β-estradiol and progesterone levels when compared with the OVX control. Amongst all the treatment doses, FVH showed maximum increase in the 17β-estradiol and progesterone levels indicating its dose dependent estrogenic potential ( Table 1) .
Effect of ethanolic extract of F. vestita tubers on uterine weight
Uteri undergo innumerable physiological and biochemical changes under the influence of ovarian hormones such as estrogen and progesterone. 8 Administration of estrogenic substances to ovariectomized rats often leads to proliferative changes in the uterine endometrium. 35 Animals in OVX control showed significant decrease (p < 0.001) in the uterine weight when compared with the normal control due to the loss of ovaries. Administration of estradiol valerate showed a significant (p < 0.001) increase in the uterine weight. Animals treated with FVL did not show significant increase in the uterine weight when compared with the OVX control. Animals treated with FVH and FVM showed significant increase (p < 0.001) in the uterine weight when compared with OVX control (Table 2) . Similar results have been reported earlier wherein plant extracts of estrogenic nature increased uterine weight in ovariectomized rat. [36] [37] Estrogenic potency and efficacy have traditionally been expressed in terms of uterotrophic effects in ovariectomized female rats. 38 In this study, the increase in uterine wet weight was successive and gradual with the increase in dose of the extract of F. vestita.
Effect of ethanolic extract of F. vestita tubers on uterine glycogen content
The energy source for female reproductive system is glycogen and estrogens have been reported to increase the hexose transport into the rat uterus thereby increasing the synthesis of glycogen in the uterus. 6, 39 The decrease in levels of uterine glycogen in the OVX control may be due to the estrogen deficiency. Animals treated with the plant extract showed (Table 2 ). Significant increase in uterine glycogen content was observed in the animals treated with FVH (p < 0.001) when compared to the OVX control and the result was equivalent to the animals treated with estradiol valerate (p < 0.001).
Effect of ethanolic extract of F. vestita tubers on uterine G6PDH and LDH levels
G6PDH is the first enzyme in the pentose phosphate pathway which provides pentose phosphates and reducing equivalents in the form of NADPH. Estrogen is known to have a direct influence on glycogen synthesis and is a potent stimulator of G6PDH and LDH activities in the uterus of OVX rats. 40 The OVX control showed significant decrease (p < 0.001) in the G6PDH and LDH levels as compared to the normal control. Significant increase (p < 0.001) in the levels of G6PDH and LDH (except G6PDH level in low dose; p < 0.05) were observed in the animals treated with all the three doses of plant extract and estradiol valerate when compared with the OVX control ( Table 2) .
Effect of ethanolic extract of F. vestita tubers on Cholesterol, HDL and Triglycerides
Estrogen has been reported as a beneficial factor in preventing cardiovascular diseases like atherosclerosis by keeping plasma cholesterol levels low in premenopausal women. Postmenopausal women lose this protection because of dramatic decrease in estrogen levels as a result of natural atrophy of the ovaries. [41] [42] Significant increase (p < 0.001) in the cholesterol, HDL and triglycerides levels in OVX control were observed when compared to normal control group. Animals treated with the estradiol valerate showed significant decrease (p<0.001) in the levels of these markers as compared to OVX control. Significant reduction in the levels of cholesterol (p < 0.01), HDL (p < 0.001) and triglycerides (p < 0.001) were observed in the rats treated with FVH as compared to the OVX control group (Table 2) .
Histopathological evaluation
The uterine histology of the sham-operated rats showed single layered columnar epithelial cells (LE), numerous and irregular endometrial glands (EG). The compact arrangement of the myometrium (M) and perimetrium (P) layer were also observed. The uterine section of OVX control rats revealed changes characterized by atrophy of the uterus and more intracellular spaces. There was noteworthy decrease in the number of endometrial glands (EG) with disappearance of lumen (LE) at some places, disorganization of epithelial cell lining and poor vascularity. This condition was recovered by FVL which showed histological changes like hydrometra, epithelial proliferation and endometrial glandular hyperplasia. Animals treated with estradiol valerate showed intact luminal epithelium with low columnar cells and regular distribution of mitotic figures. Endometrial layer showed increase in the number of endometrial glands as well as developed vascular layer and connective tissue. However, FVH was effective than OVX control, FVL and FVM and caused changes in the uterus which exhibited hypertrophy of stromal and endometrial glandular cells, epithelial hyperplasia and increased vascularity. Endometrial layer was well developed with more number of endometrial glands lined with simple columnar epithelium. FVH was found to be more effective on proliferation of endometrial glands than on the luminal epithelium ( Figure 3 ). An increased mitotic activity of uterine tissues was clearly evident in the animals treated with high dose of plant extract indicating its estrogenic nature. 43 Estrogenic potential of the ethanolic extract of F. vestita tubers at three dose levels was evaluated in OVX female albino Wistar rat model in terms of biochemical markers such as estrogen, progesterone, LDH, G6PDH, cholesterol, HDL, triglycerides, uterine weight and uterine glycogen content. Marked recovery of these biochemical markers were observed in the animals treated with F. vestita tubers as compared to OVX control group indicating estrogenic potential of this plant and results were at par with the estradiol valerate treatment. The improved histoarchitecture of the uterus was observed in histopathological evaluation of animals treated with the ethanolic extract of F. vestita tubers as compared to the animals of OVX control group. This indicates the ability of plant to proliferate luminal epithelium and endometrial cells. Thus, the estrogenic activity shown by ethanolic extract of F. vestita tubers can be attributed to the presence of phytoestrogens like genistein. From the above observations it can be concluded that the standardized ethanolic extract of F. vestita tubers at high dose level showed the promising effects on the physical, histological and biochemical parameters of the uterine tissue.
CONCLUSION
Findings of the current study, therefore suggest that the extract could form a basis for phytotherapeutic preparations which might help raise the market value of F. vestita tubers. Such plants can also be used as an alternative therapy for menopausal syndrome. 
